ThinkSabio

$SNDX

$12.80▲ -6.1% YTD

10 SEC 13D/G filings tracked · Last updated Nov 2, 2026

Filing History
News
SNDX ▼ -6.1% - Syndax Pharmaceuticals, Inc.
CP $12.80▲ -6.1%Nov 2, 2026 · ThinkSabio Blog

$SNDX - Syndax Reports Third Quarter 2026 Financial Results and Provides Business Update…

News
SNDX ▼ -6.1% - Syndax Pharmaceuticals, Inc.
CP $12.80▲ -6.1%Nov 2, 2026 · ThinkSabio Blog

$SNDX - Syndax Announces CFO Transition – Aaron A. Ondrey Appointed Chief Financial Officer…

News
SNDX ▼ -0.7% - Syndax Pharmaceuticals, Inc.
CP $14.04▲ -0.7%Oct 30, 2026 · ThinkSabio Blog

$SNDX - Syndax’s Revuforj® (revumenib) Wins Prestigious 2026 Prix Galien USA Award for Best Product for Rare/Orphan Diseases…

News
SNDX ▼ -0.4% - Syndax Pharmaceuticals, Inc.
CP $14.09▲ -0.4%Oct 30, 2026 · ThinkSabio Blog

$SNDX - Syndax Announces Participation in November Investor Conferences…

News
SNDX ▲ +0.1% - Syndax Pharmaceuticals, Inc.
CP $13.40▲ +0.1%Oct 26, 2026 · ThinkSabio Blog

$SNDX - Syndax to Announce Third Quarter 2026 Financial Results and Host Conference Call and Webcast on November 2, 2026…

News
SNDX ▲ +0.9% - Syndax Pharmaceuticals, Inc.
CP $13.65▲ +0.9%Oct 15, 2026 · ThinkSabio Blog

$SNDX - Syndax’s Revuforj® (revumenib) Named to TIME’s Best Inventions of 2026 List…

News
SNDX ▼ -17.6% - Syndax Pharmaceuticals, Inc.
CP $13.98▲ -17.6%Oct 12, 2026 · ThinkSabio Blog

$SNDX - Syndax Announces Topline Results from MAXPIRe Phase 2 Trial of Axatilimab in Idiopathic Pulmonary Fibrosis…

News
SNDX ▼ -3.4% - Syndax Pharmaceuticals, Inc.
CP $17.60▲ -3.4%Oct 2, 2026 · ThinkSabio Blog

$SNDX - Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)…

News
SNDX ▼ -0.3% - Syndax Pharmaceuticals, Inc.
CP $19.29▲ -0.3%Sep 1, 2026 · ThinkSabio Blog

$SNDX - Syndax Announces Participation in September Investor Conferences…

SEC 13D/G
SNDX - Syndax Pharmaceuticals, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks Simplified
$19.92▼ -6.48%Aug 7, 2026 · ThinkSabio Blog

$SNDX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #SNDX Syndax Pharmaceuticals, Inc. : $19.92 Sector: Healthcare |…